Comparar métodos
Revisa los métodos seleccionados uno junto a otro; las filas que difieren aparecen resaltadas.
| Inventario de Depresión de Beck-II (BDI-II)× | Impresión Global del Paciente sobre el Cambio (PGIC)× | |
|---|---|---|
| Campo | Psicología clínica | Psicología clínica |
| Familia | Process / pipeline | Process / pipeline |
| Año de origen≠ | 1996 | 1976 |
| Autor original≠ | Aaron T. Beck | William Guy |
| Tipo≠ | Self-report questionnaire | Self-report single-item rating |
| Fuente seminal≠ | Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Beck Depression Inventory (2nd ed.). San Antonio, TX: The Psychological Corporation. ISBN: 9780151840045 | Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health, US Department of Health, Education, and Welfare. link ↗ |
| Alias | BDI-II, Beck Depression Inventory Second Edition | PGIC, Patient Global Impression of Change Scale |
| Relacionados | 4 | 4 |
| Resumen≠ | The Beck Depression Inventory-II is a 21-item self-report instrument designed to assess the presence and severity of depressive symptoms in adolescents and adults. Originally published by Aaron T. Beck in 1961 and revised significantly in 1996, the BDI-II is one of the most widely used depression assessment tools in clinical psychology and psychiatry. It is copyrighted and distributed by Pearson Assessments, and measures both cognitive and somatic symptoms of depression across a two-week timeframe. | The Patient Global Impression of Change is a single-item, seven-point rating scale asking patients to report their overall impression of change since treatment initiation. Originally published by William Guy in the ECDEU Assessment Manual in 1976, the PGIC has become a standard co-primary endpoint in clinical trials assessing treatment efficacy. The scale is endorsed by the FDA as a patient-reported outcome measure for demonstrating clinical benefit. Despite its simplicity, the PGIC captures patients' holistic perception of improvement—integrating symptom reduction, functional recovery, and subjective well-being. |
| ScholarGateConjunto de datos ↗ |
|
|